Clinical Trials

Retinal Vein Occlusion
SAPPHIRE (Currently Enrolling)
Study of the safety and efficacy of Suprachoroidal CLS-TA in conjunction with intravitreal aflibercept (Eylea) in the treatment of retinal vein occlusion.
Phase 3 Study
This study will evaluated the combination of Suprachoroidal CLS-TA and Eylea in improving best corrected visual acuity in patients with retinal vein occlusion.
More information found at ClinicalTrial.gov
or call our office (541) 770-2020

Diabetes Research
Regeneron PANORAMA (Currently Enrolling)
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
Phase 3 Study
This study will assess the efficacy of intravitreal aflibercept (Eylea) in participants with moderately severe to severe nonproliferative diabetic retinopathy.
More information found at ClinicalTrial.gov
or call our office (541) 770-2020

Age-Related Macular Degeneration Research
AVENUE (Currently Enrolling)
A Proof-of-Concept Study of RG7716 in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD).
Phase 2 Study
This study will evaluate the safety, tolerability, pharmacokinetics, and efficacy of RG7716 in participants with subfoveal CNV secondary to AMD.
More information found at ClinicalTrial.gov
or call our office (541) 770-2020